Within its last year performance, RAPT fell by -86.34%, with highs and lows ranging from $9.65 to $0.79, whereas the simple moving average fell by -35.02% in the last 200 days.
On December 26, 2024, H.C. Wainwright Upgraded RAPT Therapeutics Inc (NASDAQ: RAPT) to Buy. A report published by Stifel on November 13, 2024, Downgraded its rating to ‘Hold’ for RAPT. Piper Sandler also Downgraded RAPT shares as ‘Neutral’, setting a target price of $2 on the company’s shares in a report dated November 11, 2024. Wolfe Research May 14, 2024d its ‘Outperform’ rating to ‘Peer Perform’ for RAPT, as published in its report on May 14, 2024. Barclays also rated the stock as ‘Equal Weight’.
Analysis of RAPT Therapeutics Inc (RAPT)
To gain a thorough understanding of RAPT Therapeutics Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -77.09% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 4.87, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and RAPT is recording an average volume of 943.07K. On a monthly basis, the volatility of the stock is set at 9.95%, whereas on a weekly basis, it is put at 10.53%, with a loss of -20.26% over the past seven days. Furthermore, long-term investors anticipate a median target price of $6.00, showing growth from the present price of $1.22, which can serve as yet another indication of whether RAPT is worth investing in or should be passed over.
How Do You Analyze RAPT Therapeutics Inc Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 47.81%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 45.20% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
RAPT shares are owned by institutional investors to the tune of 45.20% at present.
